Fraction size in external beam radiation therapy in the treatment of melanoma
- PMID: 1995527
- DOI: 10.1016/0360-3016(91)90053-7
Fraction size in external beam radiation therapy in the treatment of melanoma
Abstract
RTOG 83-05 was a prospective randomized trial evaluating the effectiveness of high dose per fraction irradiation in the treatment of melanoma. Retrospective analysis suggested a dose response curve of melanoma to external beam irradiation as the dose per fraction is increased. RTOG 83-05 randomized patients with measureable lesions to 4 x 8.0 Gy in 21 days once weekly to 20 x 2.5 Gy in 26-28 days, 5 days a week. One hundred thirty-seven patients were randomized and 126 patients were evaluable: 62 patients in the 4 x 8.0 Gy arm and 64 patients in 200 x 2.5 Gy arm. Patient characteristics were essentially identical. Stratification was performed on lesions less than 5 cm or greater than or equal to 5 cm. The study was closed on May 31, 1988 when interim statistical analysis suggested that further accrual would not reveal a difference between arms. Response rate overall was complete remission 23.8%, partial remission 34.9%. The 4 x 8.0 Gy arm exhibited a complete remission of 24.2% and partial remission of 35.5%. The 20 x 2.5 Gy arm exhibited a complete remission of 23.4% and partial remission of 34.4%. There was no difference between arms.
Similar articles
-
A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1837-9. doi: 10.1016/0360-3016(85)90042-2. Int J Radiat Oncol Biol Phys. 1985. PMID: 4044346 Clinical Trial.
-
Adjuvant irradiation for axillary metastases from malignant melanoma.Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):964-72. doi: 10.1016/s0360-3016(01)02742-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 11958890
-
Malignant melanoma: analysis of dose fractionation in radiation therapy.Radiology. 1987 Sep;164(3):607-10. doi: 10.1148/radiology.164.3.3112864. Radiology. 1987. PMID: 3112864
-
Radiation therapy as primary and adjuvant treatment for local and regional melanoma.Cancer Control. 2008 Jul;15(3):233-8. doi: 10.1177/107327480801500306. Cancer Control. 2008. PMID: 18596675 Review.
-
[Radiotherapy of malignant melanoma of the skin].Praxis (Bern 1994). 2001 Mar 8;90(10):397-402. Praxis (Bern 1994). 2001. PMID: 11305185 Review. German.
Cited by
-
Radiotherapy in the Treatment of Subcutaneous Melanoma.Cancers (Basel). 2021 Nov 22;13(22):5859. doi: 10.3390/cancers13225859. Cancers (Basel). 2021. PMID: 34831017 Free PMC article. Review.
-
Stereotactic ablative radiation therapy for extracranial metastases from malignant melanoma: An international multi-institutional analysis.J Radiosurg SBRT. 2025;9(3):199-205. J Radiosurg SBRT. 2025. PMID: 40476283
-
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG).Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):632-46. doi: 10.1016/j.ijrobp.2016.01.038. Int J Radiat Oncol Biol Phys. 2016. PMID: 27131079 Free PMC article. Review.
-
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.Clin Cancer Res. 2020 Jul 1;26(13):3193-3201. doi: 10.1158/1078-0432.CCR-19-3936. Epub 2020 Mar 23. Clin Cancer Res. 2020. PMID: 32205463 Free PMC article. Clinical Trial.
-
Palliative radiotherapy for Japanese patients with malignant melanoma: a single-institution experience.Jpn J Radiol. 2016 Feb;34(2):125-9. doi: 10.1007/s11604-015-0484-4. Epub 2015 Dec 14. Jpn J Radiol. 2016. PMID: 26666437
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical